Increased levels of SOD, HO-1, and GSH and decreased levels of MDA in DMF- or MMF-treated mice with MCAO further support the notion that DMF and MMF protect against cerebral ischemia–reperfusion injury and promote recovery via an Nrf2-dependent antioxidant pathway. This evidence concerns the gene NFE2L2 and brain ischemia.